Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

PURPOSE: Sensitivity to a tyrosine kinase inhibitor (TKI) is correlated with the presence of somatic mutations that affect the kinase domain of epidermal growth factor receptor (EGFR). Development of resistance to TKI is a major therapeutic problem in non-small cell lung cancer (NSCLC). Aim of this...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sudo, Makoto, Chin, Tan Min, Mori, Seiichi, Doan, Ngan B., Said, Jonathan W., Akashi, Makoto, Koeffler, H. Phillip
Format:	Artigo
Language:	Inglês
Published:	Springer-Verlag 2013
Subjects:	Original Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3636434/ https://ncbi.nlm.nih.gov/pubmed/23515752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2132-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

Similar Items